TABLE 2.

Major components of SYTZD by network pharmacology analysis.

Molecule name	OB (%)	DL	Compound structure	CAS
diosgenin	80.88	0.81		512-04-9
hancinol	64.01	0.37		108864-50-2
Denudatin B	61.47	0.38		87402-88-8
(-)-taxifolin	60.51	0.27		480-18-2
hancinone C	59.05	0.39		111843-10-8
Kadsurenone	54.72	0.38		95851-37-9
AIDS180907	45.33	0.77		76996-28-6
Stigmasterol	43.83	0.76		83-48-7
Isofucosterol	43.78	0.76		18472-36-1
Doradexanthin	38.16	0.54		4418-73-9
CLR	37.87	0.68		57-88-5
24-Methylcholest-5-enyl-3belta-O-glucopyranoside_qt	37.58	0.72		474-63-5
Campesterol	37.58	0.71		474-62-4
Dioscoreside C_qt	36.38	0.87		344912-80-7
Methylcimicifugoside_qt	31.69	0.24		66176-93-0
piperlonguminine	30.71	0.18		5950-12-9
EINECS 213-897-0	71.96	0.72		1061-54-7

Note: OB, oral bioavailability; DL, drug likeness.